Free Trial

Acorn Capital Advisors, LLC Top Holdings and 13F Report (2025)

About Acorn Capital Advisors, LLC

Investment Activity

  • Acorn Capital Advisors, LLC has $149.95 million in total holdings as of March 31, 2025.
  • Acorn Capital Advisors, LLC owns shares of 22 different stocks, but just 10 companies or ETFs make up 80% of its holdings.
  • Approximately 3.82% of the portfolio was purchased this quarter.
  • About 0.02% of the portfolio was sold this quarter.
  • This quarter, Acorn Capital Advisors, LLC has purchased 21 new stocks and bought additional shares in 7 stocks.
  • Acorn Capital Advisors, LLC sold shares of 2 stocks and completely divested from 0 stocks this quarter.

Largest Holdings

CG ONCOLOGY INC
$27,721,764
UroGen Pharma
$16,770,311
Trevi Therapeutics
$13,491,069

Largest New Holdings this Quarter

05153U107 - Aura Biosciences
$1,453,362 Holding

Largest Purchases this Quarter

Y-mAbs Therapeutics
373,562 shares (about $1.65M)
Aura Biosciences
590,508 shares (about $1.45M)
Candel Therapeutics
212,608 shares (about $1.20M)
Trevi Therapeutics
143,796 shares (about $904.48K)
VYNE Therapeutics
328,968 shares (about $519.77K)

Largest Sales this Quarter

MURAL ONCOLOGY PLC
16,364 shares (about $20.62K)
Aadi Bioscience
7,689 shares (about $13.69K)

Sector Allocation Over Time

Map of 500 Largest Holdings ofAcorn Capital Advisors, LLC

 
 
Selling
 
 
Neutral
 
 
Buying
Issuer NameHoldings ValueApproximate Purchase/SaleChange in SharesShares Held% of PortfolioSector
CG ONCOLOGY INC
$27,721,7640.0%1,131,50118.5%COM
UroGen Pharma Ltd. stock logo
URGN
UroGen Pharma
$16,770,3110.0%1,516,30311.2%Medical
Y-mAbs Therapeutics, Inc. stock logo
YMAB
Y-mAbs Therapeutics
$14,332,764$1,654,880 13.1%3,235,3879.6%Medical
Trevi Therapeutics, Inc. stock logo
TRVI
Trevi Therapeutics
$13,491,069$904,477 7.2%2,144,8449.0%Medical
Candel Therapeutics, Inc. stock logo
CADL
Candel Therapeutics
$12,160,224$1,201,235 11.0%2,152,2528.1%Medical
Puma Biotechnology, Inc. stock logo
PBYI
Puma Biotechnology
$11,662,5540.0%3,940,0527.8%Medical
BICARA THERAPEUTICS
$8,383,262$13 0.0%643,3825.6%COM
Protara Therapeutics, Inc. stock logo
TARA
Protara Therapeutics
$5,451,9480.0%1,279,8003.6%Medical
Terns Pharmaceuticals, Inc. stock logo
TERN
Terns Pharmaceuticals
$5,440,6890.0%1,971,2643.6%Medical
ONKURE THERAPEUTICS INC
$5,123,7810.0%1,439,6743.4%CLASS A COM
Verastem, Inc. stock logo
VSTM
Verastem
$4,700,3730.0%779,4983.1%Medical
CYBIN INC
$4,663,402$6 0.0%734,3943.1%COM NEW
Cardiff Oncology, Inc. stock logo
CRDF
Cardiff Oncology
$4,528,8470.0%1,442,3083.0%Medical
OPTINOSE INC
$3,877,202$9 0.0%422,8142.6%COM NEW
Aadi Bioscience, Inc. stock logo
AADI
Aadi Bioscience
$2,028,066$13,686 -0.7%1,139,3631.4%Medical
X4 Pharmaceuticals, Inc. stock logo
XFOR
X4 Pharmaceuticals
$1,754,5560.0%7,310,6501.2%Medical
MURAL ONCOLOGY PLC
$1,599,841$20,619 -1.3%1,269,7151.1%COM
Aura Biosciences, Inc. stock logo
AURA
Aura Biosciences
$1,453,362$1,453,362 New Holding590,5081.0%Medical
BioAtla, Inc. stock logo
BCAB
BioAtla
$1,411,2160.0%4,032,0460.9%Medical
Q32 BIO INC.
$1,325,6510.0%803,4250.9%COM
VYNE Therapeutics Inc. stock logo
VYNE
VYNE Therapeutics
$1,241,782$519,769 72.0%785,9380.8%Medical
Acrivon Therapeutics, Inc. stock logo
ACRV
Acrivon Therapeutics
$822,6320.0%405,2370.5%Medical

Showing largest 100 holdings. View all holdings.
SEC Filings and Trading Data